Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor necrosis factor ligand superfamily member 13B (BAFF) is a cytokine crucial for B cell development, survival, and function. It interacts with receptors TACI, BCMA, and BAFFR to activate NF-kappa-B signaling, promoting B cell survival and regulating humoral immunity. Dysregulation of BAFF is implicated in autoimmune diseases.
BAFF inhibitor
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor Necrosis Factor Ligand Superfamily Member 13B (BAFF).